The Nanotherapeutics lab is dedicated to advancing the field of nanomedicine, with a focus on bridging the gap between innovative research and the development of translatable therapeutic approaches. Our mission is to further the progress of nanomedicine toward clinical translation, particularly in diseases where conventional drugs and therapies have fallen short. By leveraging the unique properties of a diverse array of nanomaterials, our lab pioneers novel therapeutic strategies aiming to overcome key clinical challenges. We develop and employ clinically relevant models and emphasise the development of combination therapies, integrating nanomedicine with existing approaches to ensure clinical applicability.